tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNTX Stock Latest News

Rein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
RatingsRein Therapeutics: Buy Rating Driven by Innovative IPF Treatment and Strong Growth Potential
16d ago
RNTX
Rein Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Rein Therapeutics Reports Q3 2025 Financial Results
17d ago
RNTX
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
PremiumRatings
Rein Therapeutics’s LTI-03 Gains Momentum with FDA Clearance and Promising Trial Developments
27d ago
RNTX
Rein Therapeutics announces publication on LTI-03
PremiumThe Fly
Rein Therapeutics announces publication on LTI-03
28d ago
RNTX
Rein Therapeutics upgraded to Buy from Hold at Brookline
PremiumThe Fly
Rein Therapeutics upgraded to Buy from Hold at Brookline
1M ago
RNTX
Rein Therapeutics Resumes Phase 2 Trial for LTI-03
PremiumCompany AnnouncementsRein Therapeutics Resumes Phase 2 Trial for LTI-03
1M ago
8K
RNTX
Rein Therapeutics receives FDA clearance to resume Phase 2 trial of LTI-03
Premium
The Fly
Rein Therapeutics receives FDA clearance to resume Phase 2 trial of LTI-03
1M ago
RNTX
Rein Therapeutics Secures Third Pre-Paid Advance
Premium
Company Announcements
Rein Therapeutics Secures Third Pre-Paid Advance
1M ago
8K
RNTX
Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03
PremiumThe Fly
Rein receives European regulatory approval to initiate Phase 2 trial of LTI-03
2M ago
RNTX
Rein Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Rein Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
RNTX
Rein Therapeutics announces publication of data on LTI-03 in IPF
PremiumThe Fly
Rein Therapeutics announces publication of data on LTI-03 in IPF
3M ago
RNTX
Rein Therapeutics Secures Second Advance in Funding Deal
PremiumCompany Announcements
Rein Therapeutics Secures Second Advance in Funding Deal
3M ago
8K
RNTX
Rein Therapeutics files to sell 10M shares of common stock for holders
PremiumThe FlyRein Therapeutics files to sell 10M shares of common stock for holders
3M ago
RNTX
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
Premium
The Fly
Home Depot reports Q2 results, SoftBank invests $2B in Intel: Morning Buzz
4M ago
F
AS
Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
Premium
The Fly
Palo Alto upgraded, Li Auto downgraded: Wall Street’s top analyst calls
4M ago
LI
TH
Rein Therapeutics Gains Approval for Phase 2 Trial
PremiumCompany Announcements
Rein Therapeutics Gains Approval for Phase 2 Trial
4M ago
8K
RNTX
Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
PremiumThe Fly
Rein announces U.K. MHRA authorized to initiate Phase 2 ‘RENEW’ trial
4M ago
RNTX
Rein Therapeutics downgraded to Hold from Buy at Brookline
PremiumThe Fly
Rein Therapeutics downgraded to Hold from Buy at Brookline
4M ago
RNTX
Rein Therapeutics Completes Promising IPF Treatment Study
PremiumCompany Announcements
Rein Therapeutics Completes Promising IPF Treatment Study
4M ago
RNTX
Rein Therapeutics Secures New Financial Agreements
PremiumCompany AnnouncementsRein Therapeutics Secures New Financial Agreements
4M ago
8K
RNTX
Rein Therapeutics enters agreements for up to $21M in financing
Premium
The Fly
Rein Therapeutics enters agreements for up to $21M in financing
4M ago
RNTX
Rein Therapeutics Elects New Director at Annual Meeting
Premium
Company Announcements
Rein Therapeutics Elects New Director at Annual Meeting
4M ago
8K
RNTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >